Rita Guerreiro
Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study
Guerreiro, Rita; Ross, Owen A.; Kun-Rodrigues, Celia; Hernandez, Dena; Orme, Tatiana; Eicher, John D.; Shepherd, Claire; Parkkinen, Laura; Darwent, Lee; Heckman, Michael G.; Scholz, Sonja W.; Troncoso, Juan C.; Pletnikova, Olga; Ansorge, Olaf; Clarimon, Jordi; Barber, Imelda S.; Braae, Anne; Brown, Kristelle; Morgan, Kevin
Authors
Owen A. Ross
Celia Kun-Rodrigues
Dena Hernandez
Tatiana Orme
John D. Eicher
Claire Shepherd
Laura Parkkinen
Lee Darwent
Michael G. Heckman
Sonja W. Scholz
Juan C. Troncoso
Olga Pletnikova
Olaf Ansorge
Jordi Clarimon
Imelda S. Barber
Anne Braae
Dr KRISTELLE BROWN KRISTELLE.BROWN@NOTTINGHAM.AC.UK
TEACHING ASSOCIATE
Kevin Morgan
Abstract
Background Dementia with Lewy bodies is the second most common form of dementia in elderly people but has been overshadowed in the research field, partly because of similarities between dementia with Lewy bodies, Parkinson’s disease, and Alzheimer’s disease. So far, to our knowledge, no large-scale genetic study of dementia with Lewy bodies has been done. To better understand the genetic basis of dementia with Lewy bodies, we have done a genome-wide association study with the aim of identifying genetic risk factors for this disorder.
Methods In this two-stage genome-wide association study, we collected samples from white participants of European ancestry who had been diagnosed with dementia with Lewy bodies according to established clinical or pathological criteria. In the discovery stage (with the case cohort recruited from 22 centres in ten countries and the controls derived from two publicly available database of Genotypes and Phenotypes studies [phs000404.v1.p1 and phs000982.v1.p1] in the USA), we performed genotyping and exploited the recently established Haplotype Reference Consortium panel as the basis for imputation. Pathological samples were ascertained following autopsy in each individual brain bank, whereas clinical samples were collected by clinical teams after clinical examination. There was no specific timeframe for collection of samples. We did association analyses in all participants with dementia with Lewy bodies, and also in only participants with pathological diagnosis. In the replication stage, we performed genotyping of significant and suggestive results from the discovery stage. Lastly, we did a meta-analysis of both stages under a fixed-effects model and used logistic regression to test for association in each stage.
Findings This study included 1743 patients with dementia with Lewy bodies (1324 with pathological diagnosis) and 4454 controls (1216 patients with dementia with Lewy bodies vs 3791 controls in the discovery stage; 527 vs 663 in the replication stage). Results confirm previously reported associations: APOE (rs429358; odds ratio [OR] 2·40, 95% CI 2·14–2·70; p=1·05 × 10–⁴⁸), SNCA (rs7681440; OR 0·73, 0·66–0·81; p=6·39 × 10–¹⁰), and GBA (rs35749011; OR 2·55, 1·88–3·46; p=1·78 × 10–⁹). They also provide some evidence for a novel candidate locus, namely CNTN1 (rs7314908; OR 1·51, 1·27–1·79; p=2·21 × 10–⁶); further replication will be important. Additionally, we estimate the heritable component of dementia with Lewy bodies to be about 36%.
Interpretation Despite the small sample size for a genome-wide association study, and acknowledging the potential biases from ascertaining samples from multiple locations, we present the most comprehensive and well powered genetic study in dementia with Lewy bodies so far. These data show that common genetic variability has a role in the disease.
Citation
Guerreiro, R., Ross, O. A., Kun-Rodrigues, C., Hernandez, D., Orme, T., Eicher, J. D., Shepherd, C., Parkkinen, L., Darwent, L., Heckman, M. G., Scholz, S. W., Troncoso, J. C., Pletnikova, O., Ansorge, O., Clarimon, J., Barber, I. S., Braae, A., Brown, K., & Morgan, K. (2018). Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study. Lancet Neurology, 17(1), 64-74. https://doi.org/10.1016/S1474-4422%2817%2930400-3
Journal Article Type | Article |
---|---|
Acceptance Date | Nov 16, 2017 |
Online Publication Date | Dec 16, 2017 |
Publication Date | Jan 30, 2018 |
Deposit Date | Nov 20, 2017 |
Publicly Available Date | Dec 16, 2017 |
Journal | Lancet Neurology |
Print ISSN | 1474-4422 |
Electronic ISSN | 1474-4465 |
Publisher | Elsevier |
Peer Reviewed | Peer Reviewed |
Volume | 17 |
Issue | 1 |
Pages | 64-74 |
DOI | https://doi.org/10.1016/S1474-4422%2817%2930400-3 |
Public URL | https://nottingham-repository.worktribe.com/output/908115 |
Publisher URL | https://www.sciencedirect.com/science/article/pii/S1474442217304003 |
Additional Information | 65 authors in total |
Contract Date | Nov 20, 2017 |
Files
2017_DLB_GWAS_draft_for_circulation.pdf
(703 Kb)
PDF
Copyright Statement
Copyright information regarding this work can be found at the following address: http://creativecommons.org/licenses/by-nc-nd/4.0
You might also like
Heritability and genetic variance of dementia with Lewy bodies
(2019)
Journal Article
A comprehensive screening of copy-number variability in dementia with Lewy bodies
(2018)
Journal Article
A comprehensive assessment of benign genetic variability for neurodegenerative disorders
(2018)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search